AI Summary
Summary: Scientists have developed a low-cost microfluidic device that can improve the safety of cell therapy for spinal cord injury patients. The device can remove potentially tumor-forming stem cells before transplantation.
A tiny microfluidic device can improve cell therapy techniques for spinal cord injury patients. The device can remove a large percentage of stem cells that have not yet fully become spinal cord cells, which could potentially form tumors after being transplanted into a patient.